review Open AccessTop 10% cited
Cellular pharmacology of gemcitabine
Annals of Oncology · 2006 · Vol. 17 · pp. v7–v12
Pancreatic and Hepatic Oncology ResearchDNA Repair MechanismsHIV/AIDS drug development and treatmentDeoxycytidine kinaseGemcitabineRibonucleotide reductaseCytidine deaminaseCytidineNucleosideDeoxycytidineBiochemistryDeoxyribonucleosideMechanism of action
MeSH terms
GemcitabineAntimetabolites, AntineoplasticBiological TransportDeoxycytidineHumansModels, BiologicalNeoplasms
Citations
809
FWCI
4.75
field-weighted impact
References
81
Percentile
96%
vs. same field & year
Citations per year
Cited by
Pancreatic Cancer Chemoresistance to Gemcitabine
Cancers · 2017 · 445 citations
Chemotherapy Side-Effects: Not All DNA Damage Is Equal
Cancers · 2022 · 418 citations
References
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Journal of Clinical Oncology · 1997 · 5,865 citations
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
Journal of Clinical Oncology · 2000 · 2,273 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.